Corient Capital Partners, LLC Dexcom Inc Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 6,444 shares of DXCM stock, worth $433,552. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,444
Previous 5,955
8.21%
Holding current value
$433,552
Previous $444,000
8.11%
% of portfolio
0.04%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding DXCM
# of Institutions
1,112Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.13 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.32 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.1 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.03 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$804 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...